The landscape of dementia analysis has developed considerably with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative https://duked197cmv6.wikicommunications.com/user